Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

Dr. Mehmet Oz, the Administrator of the Centers for Medicare and Medicaid Services, discussed the impending changes to the ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

THE FACTS: This is false. Cutting drug prices by more than 100% would theoretically mean that people are being paid to take ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

People who get subsidized coverage through what’s known as Medicare Savings Programs get to keep hundreds of dollars per ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

Republicans lambasted Democrats last year for subsidizing monthly payments that seniors pay for prescription drug insurance, ...